This company seems to have been delisted
Reason: Failure to Satisfy a Continued Listing Rule or Standard
Source: https://www.marketscreener.com/quote/stock/NOVUS-THERAPEUTICS-INC-34879319/news/NOVUS-THERAPEUTICS-INC-Notice-of-Delisting-or-Failure-to-Satisfy-a-Continued-Listing-Rule-or-Sta-29957955/
Reason: Failure to Satisfy a Continued Listing Rule or Standard
Source: https://www.marketscreener.com/quote/stock/NOVUS-THERAPEUTICS-INC-34879319/news/NOVUS-THERAPEUTICS-INC-Notice-of-Delisting-or-Failure-to-Satisfy-a-Continued-Listing-Rule-or-Sta-29957955/
Novus Therapeutics
NVUS
₹1,271
Share price
-5.19%
Change (1 day)
N/A
Change (1 year)
Categories
Earnings for Novus Therapeutics (NVUS)
Earnings in 2020 (TTM): -₹0.9 Billion
According to Novus Therapeutics 's latest financial reports the company's current earnings are N/A. In 2019 the company made an earning of -₹1.24 Billion a decrease over its 2018 earnings that were of -₹1.23 Billion.
Earnings history for Novus Therapeutics from 2014 to 2020
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2020 (TTM) | -₹0.9 Billion | -27.23% |
| 2019 | -₹1.24 Billion | 0.88% |
| 2018 | -₹1.23 Billion | -10.03% |
| 2017 | -₹1.37 Billion | -59.01% |
| 2016 | -₹3.32 Billion | -15.77% |
| 2015 | -₹3.95 Billion | 92.91% |
| 2014 | -₹2.05 Billion |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 | -₹14.66 Billion | 1,288.29% | 🇺🇸 USA |